News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,481 Results
Type
Article (41925)
Company Profile (333)
Press Release (665223)
Section
Business (210169)
Career Advice (2080)
Deals (36584)
Drug Delivery (100)
Drug Development (82851)
Employer Resources (171)
FDA (16491)
Job Trends (15360)
News (355496)
Policy (33833)
Tag
Academia (2575)
Alliances (51186)
Alzheimer's disease (1275)
Approvals (16441)
Artificial intelligence (157)
Bankruptcy (363)
Best Places to Work (11715)
Biotechnology (215)
Breast cancer (191)
Cancer (1390)
Cardiovascular disease (116)
Career advice (1741)
Cell therapy (285)
Clinical research (66235)
Collaboration (495)
Compensation (263)
COVID-19 (2612)
C-suite (110)
Data (1400)
Diabetes (174)
Diagnostics (6256)
Earnings (86578)
Employer resources (149)
Events (112867)
Executive appointments (402)
FDA (17172)
Funding (432)
Gene therapy (206)
GLP-1 (631)
Government (4453)
Healthcare (18876)
Infectious disease (2704)
Inflammatory bowel disease (115)
Interviews (320)
IPO (16617)
Job creations (4052)
Job search strategy (1488)
Layoffs (439)
Legal (8326)
Lung cancer (199)
Lymphoma (100)
Manufacturing (215)
Medical device (13306)
Medtech (13311)
Mergers & acquisitions (20117)
Metabolic disorders (470)
Neuroscience (1606)
NextGen Class of 2024 (6625)
Non-profit (4515)
Northern California (1701)
Obesity (268)
Opinion (207)
Patents (120)
People (58417)
Phase I (20511)
Phase II (29144)
Phase III (21858)
Pipeline (517)
Postmarket research (2651)
Preclinical (8730)
Radiopharmaceuticals (241)
Rare diseases (271)
Real estate (6240)
Regulatory (22511)
Research institute (2359)
Resumes & cover letters (358)
Southern California (1468)
Startups (3713)
United States (15332)
Vaccines (582)
Weight loss (196)
Date
Last 7 days (590)
Last 30 days (2295)
Last 365 days (35715)
2024 (35554)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54795)
2019 (47408)
2018 (35774)
2017 (33138)
2016 (32663)
2015 (38616)
2014 (32520)
2013 (27631)
2012 (29730)
2011 (30487)
2010 (28497)
Location
Africa (776)
Arizona (202)
Asia (40139)
Australia (6423)
California (3836)
Canada (1455)
China (311)
Colorado (174)
Connecticut (179)
Europe (85482)
Florida (535)
Georgia (135)
Illinois (394)
Indiana (232)
Maryland (633)
Massachusetts (3007)
Michigan (174)
Minnesota (291)
New Jersey (1117)
New York (1086)
North Carolina (760)
Northern California (1701)
Ohio (146)
Pennsylvania (929)
South America (1157)
Southern California (1468)
Texas (557)
Utah (109)
Washington State (406)
707,481 Results for "xenon pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
Xenon Pharmaceuticals Inc. announced that the company will present at the BofA Securities Health Care Conference 2024 taking place May 14-16, 2024 in Las Vegas, NV.
May 8, 2024
·
1 min read
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the Goldman Sachs 45th Annual Global Healthcare Conference taking place June 10-13, 2024 in Miami, FL.
June 5, 2024
·
1 min read
Business
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, reported financial results for the first quarter ended March 31, 2024 and provided a corporate update.
May 9, 2024
·
12 min read
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, announced that the company will present at the 2024 RBC Capital Markets Global Healthcare Conference taking place May 14-15, 2024 in New York, NY.
May 7, 2024
·
1 min read
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Xenon Pharmaceuticals Inc. today announced that the company will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place April 16-17, 2024.
April 10, 2024
·
1 min read
Press Releases
Xenon to Present at Upcoming Investor Conferences
November 14, 2024
·
1 min read
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the Stifel 2024 Virtual CNS Days event.
March 12, 2024
·
1 min read
Business
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
Xenon Pharmaceuticals Inc. announced it will report its first quarter 2024 financial and operating results after the close of U.S. financial markets on Thursday, May 9, 2024.
May 2, 2024
·
1 min read
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 23rd Annual Needham (Virtual) Healthcare Conference taking place April 8-11, 2024.
April 4, 2024
·
1 min read
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced two oral presentations highlighting XEN1101 clinical data at the American Academy of Neurology (AAN) 2024 Annual Meeting in Denver, CO.
April 16, 2024
·
4 min read
1 of 70,749
Next
